The Private Dermatologist and Skin Cancer

Ferrara, Richard J.

doi:10.1001/archderm.1960.03730020061010

Cited by 17 publications

(8 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Only one other study could be located that compared recurrence rates of nonmelanoma skin cancers treated by curettage and desiccation vs. excision in private practice. This study, from 1960, reported a raw recurrence rate of BCCs and SCCs as 2.8% (2/71) for excision and 4.9% (4/82) for curettage and desiccation 11 . The number of BCCs vs. SCCs in each treatment group was not specified.…”

Section: Discussionmentioning

confidence: 99%

“…In a recent review, Thissen et al 3 found the cumulative 5‐year recurrence rate for BCC to be 3.2–8.0% for excision and 5.7–18.8% for curettage and desiccation. (The 5.7% rate is taken from the study by Kopf et al 11 discussed above.) From this data, the authors concluded “if surgery is not contraindicated, [surgical excision] remains the treatment modality of first choice for BCCs” (p.1182).…”

Section: Discussionmentioning

confidence: 99%

“…This study, from 1960, reported a raw recurrence rate of BCCs and SCCs as 2.8% (2/71) for excision and 4.9% (4/82) for curettage and desiccation. 11 The number of BCCs vs. SCCs in each treatment group was not specified.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Recurrence Rates of Primary Nonmelanoma Skin Cancers Treated by Surgical Excision Compared to Electrodesiccation-Curettage in a Private Dermatological Practice

2002

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Recurrence Rates of Primary Nonmelanoma Skin Cancers Treated by Surgical Excision Compared to Electrodesiccation-Curettage in a Private Dermatological Practice

2002

View full text Add to dashboard Cite

show abstract

“…(2) Eighteen studies reported on populations of patients, some of which had basal cell carcinoma and others squamous cell carcinoma, but failed to separate the histologic type when reporting recurrence rates and thus could not be used for this investigation. [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19] (3) A recent study by Hall et a1.,20 which reported a short-term recurrence rate of 39% in cryotherapy, was not used because the recurrence rate was 3 times higher than that of any other author. Also, Hall et al are radiotherapists, who may not have had proper training on the administration of cryotherapy and who may have been biased against cryotherapy .…”

Section: Methodsmentioning

confidence: 99%

Long‐Term Recurrence Rates in Previously Untreated (Primary) Basal Cell Carcinoma: Implications for Patient Follow‐Up

Rowe

Carroll

Day

1989

The Journal of Dermatologic Surgery and Oncology

734

469

View full text Add to dashboard Cite

We reviewed all studies (since 1947) reporting recurrence rates for treatment of primary (previously untreated) basal cell carcinomas using surgical excision, radiotherapy, cryotherapy, curettage and electrodesiccation, and Mohs micrographic surgery. Our findings indicate that recurrences following treatment of primary basal cell carcinoma appear later than is generally acknowledged in the literature. We found that less than one-third of all recurrences appear in the first year following treatment; only 50% appear within the first 2 years following treatment; and only 66%, or nearly two-thirds, appear within the first 3 years following treatment. A good rule of thumb is that the 10-year recurrence rate is double, or 2 times, that of the 2-year recurrence rate. Furthermore, 18% of recurrences appear between the fifth and tenth year following treatment. These results held true, irrespective of treatment modality examined. Seventy-two studies reporting short-term recurrence rates (follow-up less than 5 years) had a weighted average recurrence rate of 4.2%, whereas 34 long-term studies (follow-up of 5 years) had a weighted average recurrence rate of 8.7%, or more than 2 times the short-term rate. Five-year recurrence rates by treatment modality are as follows: Mohs micrographic surgery 1.0%, surgical excision 10.1%, curettage and electrodesiccation 7.7%, radiation therapy 8.7%, and cryosurgery 7.5%. We conclude that the reporting of recurrence rate data for basal cell carcinoma should be standardized using 5-year life table analysis, and even more important is our conclusion that lifetime follow-up is necessary after treatment of primary basal cell carcinoma in order both recurrences and new primaries.

show abstract

“…The ‘real world’ applicability of high C & ED cure rates is evidenced by the fact that C & ED is one of the most commonly employed treatment modalities for skin cancer worldwide. 6,19,25,26,30,47,48,55,59,74–76 …”

Section: Cure Ratesmentioning

confidence: 99%

Curettage, electrosurgery and skin cancer

Sheridan

Dawber

2000

Aust J Dermatology

View full text Add to dashboard Cite

The scientific literature is replete with reports extolling the virtues of curettage and electrosurgery in the treatment of skin disease. Published cure rates for selected skin cancers consistently equal those for other treatment modalities, including scalpel excision. Despite this, curettage is often overlooked as a first line treatment for skin cancer. We review the evidence-based literature for patient selection criteria and curettage and electrosurgery techniques.

show abstract

The Private Dermatologist and Skin Cancer

Cited by 17 publications

References 6 publications

Recurrence Rates of Primary Nonmelanoma Skin Cancers Treated by Surgical Excision Compared to Electrodesiccation-Curettage in a Private Dermatological Practice

Recurrence Rates of Primary Nonmelanoma Skin Cancers Treated by Surgical Excision Compared to Electrodesiccation-Curettage in a Private Dermatological Practice

Long‐Term Recurrence Rates in Previously Untreated (Primary) Basal Cell Carcinoma: Implications for Patient Follow‐Up

Curettage, electrosurgery and skin cancer

Contact Info

Product

Resources

About